No Data
No Data
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $34
Cullinan Oncology Coverage Assumed by Morgan Stanley at Overweight
Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $35
Express News | Cullinan Therapeutics : Morgan Stanley Cuts Target Price to $35.00 From $38.00
Morgan Stanley Initiates Cullinan Therapeutics(CGEM.US) With Buy Rating, Announces Target Price $35
Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Cuts Target Price to $30